Does DARATUMUMAB Cause Transient ischaemic attack? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Transient ischaemic attack have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.2% of all adverse event reports for DARATUMUMAB.
48
Reports of Transient ischaemic attack with DARATUMUMAB
0.2%
of all DARATUMUMAB reports
8
Deaths
30
Hospitalizations
How Dangerous Is Transient ischaemic attack From DARATUMUMAB?
Of the 48 reports, 8 (16.7%) resulted in death, 30 (62.5%) required hospitalization.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which DARATUMUMAB Alternatives Have Lower Transient ischaemic attack Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE